$0.3180
-0.0736-18.79%
Last update: May 11, 4:00 PM
HEPION PHARMS INC by Hepion Pharmaceuticals, Inc.
HEPAOTCQB
HEPION PHARMS INC by Hepion Pharmaceuticals rose 94.5% from $0.07 to $0.13, ahead of the S&P 500's +9.8%. Its worst day was Oct 13 (−50.6%), and its low came Jan 30 at $0.03.
Nov 11, 2025 – Nov 9, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $-0.04 was reported on $0.00 revenue.
+6.9% · S&P 500 −1.7%
HEPION PHARMS INC by Hepion Pharmaceuticals closed at its lowest level of the year, 48.5% below where the year started.
Story events cover the past 12 months · Times ET
−13.2% · S&P 500 −0.3%
HEPION PHARMS INC by Hepion Pharmaceuticals shares rose 62.2%, while the S&P 500 rose 0.1%.
+62.2% · S&P 500 +0.1%
EPS of $0.00 was reported on $0.00 revenue.
+33.3% · S&P 500 −1.5%
EPS of $-0.07 was reported on $0.00 revenue.
−5.3% · S&P 500 −1.2%
HEPION PHARMS INC by Hepion Pharmaceuticals shares rose 55.3%, while the S&P 500 fell 1.5%.
+55.3% · S&P 500 −1.5%
HEPION PHARMS INC by Hepion Pharmaceuticals shares rose 56.0%, while the S&P 500 rose 1.4%.
+56.0% · S&P 500 +1.4%
EPS of $-0.08 was reported on $0.00 revenue.
+7.1% · S&P 500 −0.2%
HEPION PHARMS INC by Hepion Pharmaceuticals shares rose 79.2%, while the S&P 500 fell 0.2%.
+79.2%, the year's best day · S&P 500 −0.2%
HEPION PHARMS INC by Hepion Pharmaceuticals closed at its highest level of the year, 167.3% above where the year started.
+28.6% · S&P 500 −1.8%
Where it ended: a close of $0.13 on Nov 9, 2026. Up next: Q3 2026 earnings on Nov 24, 2026.
Nothing in the past 12 months.
All HEPA analyst actionsNothing in the past 12 months.
All HEPA dividend historyNothing in the past 12 months.
All HEPA news
